BAFNAPHARM

Bafna Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Babulal Kamelsh Kumar as Non- Executive Independent Director of the company w.e.f. February 08, 2019.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr R DWARKANATHAN as Non- Executive Independent Director of the company w.e.f. August 21, 2018.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Jitendra Pal as Company Secretary & Compliance Officer of the company w.e.f. May 28, 2018.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Nirav Vikram Maniar as Non- Executiv Independent Director of the company w.e.f. May 28, 2018.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Kamlesh Kumar as Independent Director of the company w.e.f. May 28, 2018.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Ms Nirmala L as Company Secretary & Compliance Officer of the company w.e.f. May 28, 2018.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mrs Nirmala L as Company Secretary & Compliance Officer of the company w.e.f. November 10, 2017.

Bafna Pharmaceuticals Limited has informed the Exchange that Mr.M.R.Ramachandran, Chief Finanial Officer has submitted his resignation and reliveded from services of the company effective from the closing hours of March 03, 2016.

Bafna Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 27, 2015 has appointed Mrs. K. Sabitha as an Additional Director (Woman Director) of the Company. The appointment of Mrs. K. Sabitha is subject to the approval of the shareholders at the ensuing General Meeting.

Bafna Pharmaceuticals Limited has informed the Exchange that Mr. R. S. Gowdhaman is appointed as the Company Secretary & Compliance Officer with effect from October 15, 2014 in place of Mr. K. Premnath who has resigned from the service of the Company.

Bafna Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2013 has approved the re-appointment of Mr. Bafna Mahaveer Chand as Chairman & Managing Director and Mr. Paras Bafna as Whole Time Director.

Bafna Pharmaceuticals Limited has informed the Exchange vide letter dated May 02, 2013 that the Company has appointed M/s Minepro Communications for marketing serviecs. The Company had entered into agreement with M/s. Minepro Communications for marketing services which include advertising and publicity. The Company further confirms that : 1. The above Company for any of their associates have any shareholding in the Company. 2. None of the person from the above media companies appointed any nominee Director on the Board of the Company; or, 3. There is no management control or any potential c